IL17A and lung carcinoma: Wong KK et al. reported that an increase in a single cytokine, IL-17A, without additional mutations can promote lung cancer growth by promoting inflammation using bitransgenic mice expressing a conditional IL-17A allele along with conditional KrasG12D [106].